Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
about
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentDisorders of carnitine transport and the carnitine cycleMitochondria: a new therapeutic target in chronic kidney diseaseStrategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamilyEffective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysisTranslating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitineMetabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigsHuman risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acidA moderate excess of dietary lysine lowers plasma and tissue carnitine concentrations in pigs.PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis.Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney diseaseDetection and Alterations of Acetylcarnitine in Human Skeletal Muscles by 1H MRS at 7 T.Utilisation of supplemented l-carnitine for fuel efficiency, as an antioxidant, and for muscle recovery in Labrador retrieversAcute management of propionic acidemia.Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasisRole of carnitine in diseaseL-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled studyCurrent experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Separation of carnitine and acylcarnitines in biological samples: a review.Carnitine levels in skeletal muscle, blood, and urine in patients with primary carnitine deficiency during intermission of L-carnitine supplementationA multi-ingredient containing carbohydrate, proteins L-glutamine and L-carnitine attenuates fatigue perception with no effect on performance, muscle damage or immunity in soccer players.Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin IIThe protection role of heat shock protein 70 (HSP-70) in the testes of cadmium-exposed rats.Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery.Targeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adultsA pharmacokinetic model for L-carnitine in patients receiving haemodialysisSystematic Evaluation of Key L-Carnitine Homeostasis Mechanisms during Postnatal Development in RatCarnitine in bacterial physiology and metabolism.Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients.Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates.A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depressionPrevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.Hyperammonemic encephalopathy caused by carnitine deficiency.The use of carnitine in pediatric nutrition.Pharmacokinetics of acetyl-L-carnitine given in single or multiple doses to HIV-1 Infected patients with toxic peripheral polyneuropathyNatural antioxidants in Alzheimer's disease.Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy.Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency.Timing and Duration of Drug Exposure Affects Outcomes of a Drug-Nutrient Interaction During Ontogeny.
P2860
Q22241837-447B759E-FA3A-4A4B-8060-937A3962F426Q24658342-EB4B31BE-B5DC-40E1-9B52-4FBC33FD618EQ26776397-8ED7612D-2EBF-4F9E-B14B-F199CF4E9E9EQ27010565-134D858E-A3A0-4D23-92BA-D6C9FA2106C3Q27027544-B1DD3392-B120-44E0-AE01-D60A4E038CE6Q28395286-8C86A771-6E2F-4A22-A375-F6E1D443631BQ28473135-6CF70B83-669E-42E4-A52B-DF3F116608E1Q30248988-3D50E8A1-ACF3-42AE-AB8E-075B4948086FQ30319573-0D7304A9-7682-4B62-80C0-FF44D4370966Q30319665-5EDB27A7-0EE3-4B3A-8CC1-D7825C25CF75Q33591146-916AF751-0B7D-4A10-959A-2D99CBC6BE0BQ33778979-D41494CE-F85D-4A82-A368-2C689CEEBB15Q33782385-F2A90B57-868A-46E7-863A-A6EEEB78106EQ34049906-713E6607-4619-4661-BB82-8A039150BAFCQ34094462-600D8DA7-3E43-4895-9716-89C9EAE207A7Q34618777-115FDE13-22B6-440F-BE0E-721CDB78568CQ34643225-CA33FF09-2E86-4C6C-8C66-5C7F97495A9BQ34685307-E9BE3056-41B7-443F-8460-6AEB4B75C3AFQ34978502-E363B93C-3391-4A90-BF94-39ED95CB4B4FQ35220712-41EE4168-1900-4748-AA3E-BA3474FD83D9Q35615248-BEDBE551-7BE3-4D90-AB0F-BE13E915A2FFQ35636863-EBDC60A2-F6A3-4DD5-91CA-DC6F581DB607Q35764982-A36C7131-4818-4F25-9975-E1A91A4F4144Q35980880-21858919-4742-49E1-9D4A-FD6A5CB4140EQ36021394-B64CDAE3-FA34-40E9-B3E3-1B46C432AABCQ36024680-9785CFB7-EDDC-4EAA-B421-13C79C6C069BQ36127673-EF282A97-775D-4796-B34D-CE10E32A9DE5Q36255176-299C0098-4029-4FB6-97F9-41515FD35703Q36343125-817A32AD-81F1-476F-BCAB-72F9EE222C6CQ36418591-33CA4E1F-F596-4E32-AD1B-E9A96849B296Q36424640-5B04C5D1-A5A0-4E16-97C3-EF29C6B6A8DFQ36571464-CA8D9065-1864-424C-AFDB-24B39195B3C3Q36607259-DEA530D6-C760-4DC0-8B04-9B334F89B53FQ36765315-3B3C9316-FCA7-4FB1-A44B-DCE392053730Q36914897-4BDD197B-E13B-48C4-AFF9-4167FED3054EQ37016092-0079ED77-00F7-477D-A477-106E6D7C61DFQ37105412-A045E2D4-CFCC-49EA-889E-C26C5A3E3A3BQ37305111-E5319AF7-0000-4393-89CF-8AF04BC58D7FQ37434019-7246A4C6-2975-47D4-9D8C-90B224AF2E1BQ37666701-CCFBF58E-4795-447C-BC25-AEE0A9C027E6
P2860
Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@ast
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@en
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@nl
type
label
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@ast
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@en
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@nl
prefLabel
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@ast
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@en
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@nl
P356
P1476
Kinetics, pharmacokinetics, an ...... acetyl-L-carnitine metabolism.
@en
P2093
Charles J Rebouche
P356
10.1196/ANNALS.1320.003
P407
P577
2004-11-01T00:00:00Z